Tag - pfizer

 
 

PFIZER

Japan Times
JAPAN
Jan 21, 2022
Japan approves Pfizer shot for children age 5 to 11 as omicron spreads
The health ministry has issued fast-track approval to ease the age restriction on receiving the Pfizer vaccine.
Japan Times
WORLD / Science & Health
Jan 16, 2022
The decades of discoveries before the ‘miraculous’ sprint to a vaccine
The breakthroughs behind the vaccines unfolded over decades, little by little, as scientists across the world pursued research in disparate areas.
Japan Times
WORLD / Science & Health
Jan 11, 2022
Pfizer starts making vaccine that targets both omicron and the original COVID virus
While research continues, Pfizer will evaluate the new hybrid shot against one specific to omicron and determine which should move forward by March, the firm's CEO has said.
JAPAN / Explainer
Jan 6, 2022
The ins and outs of Japan's COVID-19 booster shot rollout
Japan recommends people receive a different shot for their third doses to the one they received in the initial rollout, but what's the rationale behind that strategy?
Japan Times
WORLD / Science & Health
Dec 18, 2021
Pfizer says pandemic could extend through 2023, studies three-dose vaccine course for children
Pfizer executives said the company believed that by 2024, the disease should be endemic around the globe, meaning it would no longer be a pandemic.
Japan Times
BUSINESS
Dec 17, 2021
Pfizer will dominate $20 billion COVID-19 pill market in 2022, analysis shows
Demand for the medications is poised to outpace supply as COVID-19 spreads around the globe and scientists question how well vaccines and antibody treatments will hold up against omicron.
Japan Times
WORLD
Dec 15, 2021
Pfizer says COVID-19 pill near 90% protective against hospitalization and death
Recent lab data suggests the drug retains its effectiveness against the fast spreading omicron variant of the coronavirus.
Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
Japan Times
WORLD
Dec 8, 2021
Pfizer shot provides partial omicron shield, study finds
Researchers in South Africa found omicron reduces virus-blocking antibodies by 40-fold in people who have received two doses of the shot.
Japan Times
COMMENTARY / World
Nov 26, 2021
Did AstraZeneca keep Britain safer from COVID-19 than Europe?
It's suggested that Britain's home-grown jab may be the reason the country is faring better with the latest COVID-19 wave than Europe. Still, is there evidence for that?
Japan Times
WORLD / Science & Health
Nov 16, 2021
Pfizer to allow generic versions of its COVID-19 pill in 95 countries
A Pfizer executive said last week the market for the drug might be up to 150 million people and that many countries might also be interested in buying doses for their strategic reserves.
Japan Times
JAPAN
Nov 10, 2021
Pfizer applies for COVID-19 vaccine approval for kids age 5 to 11 in Japan
If approved by the health ministry, Pfizer's shot will be the first to be administered to children under 11 in Japan.
Japan Times
ASIA PACIFIC
Nov 8, 2021
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
Japan Times
COMMENTARY / World
Nov 7, 2021
COVID-19 drugs will change the way we live with the virus
New COVID-19 drug approvals couldn't be timelier as hospitals face massive backlogs of delayed procedures.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.'s and Merck & Co. Inc.'s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company's mRNA technology gives it an advantage.
Japan Times
JAPAN / Science & Health
Oct 28, 2021
Pfizer to seek OK for use of COVID-19 shot in children in Japan age 5 to 11
The government is hinting that it will act swiftly to make the vaccine available to children in that demographic.
Japan Times
JAPAN / Science & Health
Oct 14, 2021
Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30
Even as concerns grow about higher rates of myocarditis among young men who got the Moderna shot, the risk of developing the heart condition is still much lower than after getting COVID-19.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji